Title |
Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial
|
---|---|
Published in |
Trials, August 2020
|
DOI | 10.1186/s13063-020-04643-1 |
Pubmed ID | |
Authors |
Jesús Villar, José M. Añón, Carlos Ferrando, Gerardo Aguilar, Tomás Muñoz, José Ferreres, Alfonso Ambrós, César Aldecoa, Fernando Suárez-Sipmann, Kevin E. Thorpe, Peter Jüni, Arthur S. Slutsky |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 243 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 243 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 37 | 15% |
Student > Master | 26 | 11% |
Researcher | 18 | 7% |
Student > Doctoral Student | 14 | 6% |
Student > Postgraduate | 10 | 4% |
Other | 49 | 20% |
Unknown | 89 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 77 | 32% |
Pharmacology, Toxicology and Pharmaceutical Science | 20 | 8% |
Nursing and Health Professions | 19 | 8% |
Biochemistry, Genetics and Molecular Biology | 9 | 4% |
Engineering | 4 | 2% |
Other | 24 | 10% |
Unknown | 90 | 37% |